Ikappa Balpha Functions Through Direct Contacts with the Nuclear Localization Signals and the DNA Binding Sequences of NF-kappaB
Overview
Affiliations
We have determined the binding energies of complexes formed between Ikappa Balpha and the wild type and mutational variants of three different Rel/NF-kappaB dimers, namely, the p50/p65 heterodimer and homodimers of p50 and p65. We show that although a common mode of interaction exists between the Rel/NF-kappaB dimers and Ikappa Balpha, IkappaB alpha binds the NF-kappaB p50/p65 heterodimer with 60- and 27-fold higher affinity than the p50 and p65 homodimers, respectively. Each of the three flexibly linked segments of the rel homology region of Rel/NF-kappaB proteins (the nuclear localization sequence, the dimerization domain, and the amino-terminal DNA binding domain) is directly engaged in forming the protein/protein interface with the ankyrin repeats and the carboxyl-terminal acidic tail/PEST sequence of Ikappa Balpha. In the cell, Ikappa Balpha functions to retain NF-kappaB in the cytoplasm and inhibit its DNA binding activity. These properties are a result of the direct involvement of the nuclear localization sequences and of the DNA binding region of NF-kappaB in complex with Ikappa Balpha. A model of the interactions in the complex is proposed based on our observations and the crystal structures of Rel/NF-kappaB dimers and the ankyrin domains of related proteins.
Zhu N, Rogers W, Heidary D, Huxford T Genes Dev. 2024; 38(11-12):528-535.
PMID: 38960718 PMC: 11293385. DOI: 10.1101/gad.351892.124.
Tan S, Zou Z, Luan X, Chen C, Li S, Zhang Z Molecules. 2024; 29(8).
PMID: 38675532 PMC: 11052049. DOI: 10.3390/molecules29081711.
Chen H, Zhang L, Du S, Yang D, Cui X, Zhao H BMC Complement Med Ther. 2024; 24(1):113.
PMID: 38448925 PMC: 10916329. DOI: 10.1186/s12906-024-04408-2.
Xue M, Wang W, He H, Li L, Zhang X, Shi H J Virol. 2022; 96(24):e0138822.
PMID: 36448799 PMC: 9769389. DOI: 10.1128/jvi.01388-22.
TCR mimic compounds for pHLA targeting with high potency modalities in oncology.
Gerber H, Presta L Front Oncol. 2022; 12:1027548.
PMID: 36338746 PMC: 9635445. DOI: 10.3389/fonc.2022.1027548.